Clinical Trial: A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

U.S., Nov. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07223047) titled 'A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies' on Oct. 29.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and efficacy of BMS-986523 alone and in combination with anti-cancer agents in participants with advanced solid malignancies

Study Start Date: Nov. 26

Study Type: INTERVENTIONAL

Condition: Advanced Solid Malignancies Non-small Cell Lung Cancer (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma (PDAC)

Intervention: DRUG: BMS-986523

Specified dose on spe...